CROMSOURCE Appoints Chief Medical Officer and Expands Medical Affairs Services

VERONA, Italy, September 7, 2016 /PRNewswire/ --

CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced today the appointment of its new Chief Medical Officer, Dr. Grzegorz Rychlik, and the expansion of its Medical Affairs Services department.

(Logo: )

Dr. Rychlik has more than 26 years of experience in the pharmaceutical industry. He has held positions of increasing responsibility with sponsor and service companies of various sizes, including large, global organizations such as Pfizer, Novartis, and Parexel, as well as virtual, small, and mid-sized enterprises.  Dr. Rychlik's most recent position was Managing Director with MRCD Pharma Services Ltd in the United Kingdom, and prior to that he served as Medical Director and Chief Medical Officer for various organizations. His therapeutic expertise is closely aligned with CROMSOURCE's key areas of focus and expertise, namely Oncology, Ophthalmology, Respiratory, Cardiovascular, CNS, and Medical Devices.  

"The addition of an experienced and respected medical professional such as Greg strongly positions CROMSOURCE to be able to further support the increasingly complex product development needs of our clients. Additionally, as we expand our Medical Affairs offering we will optimize and grow our consultancy and medical services to better serve our clients," stated Dr. Oriana Zerbini, Founder and Chief Executive Officer of CROMSOURCE.

Dr. Troy McCall, CROMSOURCE Chief Operating Officer, added, "We are very pleased to have Dr. Rychlik join the CROMSOURCE team. Under his leadership, CROMSOURCE will expand our Medical Monitoring, Pharmacovigilance, and Medical Writing services to meet growing client needs. Having highly experienced and skilled individuals such as Greg within the Medical Affairs Services group will allow for the optimization and standardization of interdependent processes, while leveraging efficiencies and ensuring that the highest level of quality is delivered."


CROMSOURCE is an ISO-certified, international contract research organization providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries.  Specializing in clinical development and staffing solutions they offer a flexible approach to ensure their clients' unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and contract price.  This guarantees their clients that trials are delivered on-time and within the contract price with no CRO-initiated change orders. CROMSOURCE operates offices across all regions of Europe and North America. For more information, visit



CONTACT: Contact Info: April McCall,,+1-919-896-0280

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234